Company Filing History:
Years Active: 2016-2024
Title: C Andrew Stewart: Innovator in Chimeric Antigen Receptors
Introduction
C Andrew Stewart is a prominent inventor based in Frederick, MD (US), known for his significant contributions to the field of immunotherapy. He holds a total of four patents, showcasing his innovative approach to cancer treatment through advanced technologies.
Latest Patents
Among his latest patents are the Anti-BCMA chimeric antigen receptors. These chimeric antigen receptors (CARs) are designed to target BCMA, exhibiting enhanced properties such as improved binding to BCMA and increased efficacy in killing BCMA-expressing cancer cells. The applications of these CARs extend to immune cells, including T cells, and involve various compositions and methods for their use.
Career Highlights
C Andrew Stewart has worked with notable organizations, including Cartesian Therapeutics, Inc. and the National Institutes of Health, a component of the US Department of Health & Human Services. His work in these institutions has been pivotal in advancing research and development in the field of immunotherapy.
Collaborations
He has collaborated with esteemed colleagues such as Yi Zhang and Metin Kurtoglu, contributing to a dynamic research environment that fosters innovation and discovery.
Conclusion
C Andrew Stewart's work in developing chimeric antigen receptors represents a significant advancement in cancer treatment. His innovative spirit and dedication to research continue to impact the field positively.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.